Hiroaki Kuroda

Differential Crizotinib Response Duration Among <i>ALK</i> Fusion Variants in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

Tatsuya Yoshida, Yuko Oya, Kosuke Tanaka et al. · Journal of Clinical Oncology · 2016 · 250 citations

Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

Keiju Aokage, Kenji Suzuki, Hisashi Saji et al. · The Lancet Respiratory Medicine · 2023 · 194 citations

Surgical Oncology, Phase 3, Medicine +10

In Vivo Monitoring of Peripheral Circadian Clocks in the Mouse

Yu Tahara, Hiroaki Kuroda, Keisuke Saito et al. · Current Biology · 2012 · 180 citations · Full text

Optogenetics, Sleep, Alertness +12

RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase

Jeffrey A. Knauf, Hiroaki Kuroda, Saswata Basu et al. · Oncogene · 2003 · 176 citations

Signal Transduction, Ret/ptc-induced Dedifferentiation, Signaling Pathway +9

Tumor Cell–Derived Angiopoietin-like Protein ANGPTL2 Is a Critical Driver of Metastasis

Motoyoshi Endo, Masahiro Nakano, Tsuyoshi Kadomatsu et al. · Cancer Research · 2012 · 141 citations

Tumor Biology, Increased Angptl2 Expression, Angiogenesis +14